임상 레이더 AI
임상시험 NCT06782178 (ACALL)은(는) 측두하악관절 디스크 전위, Temporomandibular Joint Disc Displacement, Without Reduction, Temporomandibular Disorders (TMD)에 대해 모집중 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요.
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰

TMJ Arthroscopy Compared to Arthrocentesis in Disc Displacement Without Reduction (ACALL)

모집중
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '시험 설명하기'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT06782178 (ACALL)은(는) 측두하악관절 디스크 전위, Temporomandibular Joint Disc Displacement, Without Reduction, Temporomandibular Disorders (TMD)에 대해 알아보는 중재연구입니다. 현재 상태는 모집중이며, 연구는 2025년 4월 1일에 시작되어 100명의 참여자를 모집하고 있습니다. 카롤린스카 연구소이(가) 진행하며, 2030년 2월 1일까지 완료될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2025년 6월 29일에 갱신되었습니다.
간단한 개요

The goal of this clinical trial is to compare the intervention arthroscopic lysis and lavage to the intervention arthrocentesis in treating disabling and painful temporomandibular joint disc displacement without reduction. The main questions it aims to answer are:

  • Which surgical method that best improves mouth opening capacity, TMJ pain, and TMJ disability?
  • If any pre- or peri-operative variable/-s could be identified as a predictor for surgical outcome? Researchers will compare arthroscopic lysis and lavage to arthrocentesis to see if arthroscopic lysis and lavage works better to treat temporomandibular joint disc displacement.

Participants will:

  • Have one of the two interventions under general anesthesia, not knowing which intervention.
  • Visit an external clinic for regular checkups at 1, 3, 6, 12, and 24 months after surgery.
  • Answer three different quality of life surveys at the checkups.
상세한 설명
  1. BACKGROUND The temporomandibular joint (TMJ) is a bilateral joint comprised of two cartilage covered bone surfaces that articulates against each other during mouth opening and closing. A dense cartilage disc is situated between the two joint surfaces.

    Disc displacement (DD) is characterised by an improper position of the TMJ disc relative to the articulating surfaces and affects up to 30% of the population. DD without reduction (DDwoR) is a sub-diagnosis of DD where the inaccurate disc position and associated inflammation hampers the TMJ movement and osteoarthritis successively develops. The affected patient suffers from reduced mouth opening capacity and pain when opening the mouth and during chewing, which leads to restrains in food intake, speech and social activities. A recent Swedish publication has shown that patients with TMJ disorders had more days of work disability (2-3 times longer) compared to a non-TMD cohort followed over a ten year period. The reliance on social security benefits in the group of patients that had TMJ surgery more than once were more accentuated compared to other TMJ disorder patients.

    The primary treatment for DDwoR is non-surgical, i.e., physiotherapy, pharmacological treatment and/or occlusal splint therapy. If non-surgical treatment fails, arthroscopic lysis and lavage (ALL) or arthrocentesis (AC) might be considered. ALL is performed with a rod-shaped lens inserted into the TMJ cavity enabling direct visualisation, The operative procedure involves manipulation of disc position, release of adhesions (lysis), and irrigation (lavage) of the joint with either saline solution or Ringer's solution. Generally the procedure is performed under general anaesthesia, but there are reports on ALL performed in local anaesthesia or conscious sedation. Success rates of 75-88 % is reported. In AC, two needles are inserted into the joint cavity to irrigate the TMJ. The method does not allow visualisation of the joint. AC is often performed together with opening and closing manoeuvres of the mandible to enable manipulation of the discs position. AC is reported to be executed under general anaesthesia, but also under local anaesthesia or conscious sedation. AC is most often reported to have a higher success rate compared to ALL, with figures ranging from 66-100 %. Although, the compared figures are taken from cohort studies with no control group. There are a few randomised and controlled studies comparing ALL to AC. Fridrich et al. performed a randomised study without blinding and also incorporates two different diagnoses, DDwoR and disc displacement with reduction (DDwR). The patient sample was small, 20 patients. Murakami et al. conducted a study including three interventions: non-surgical , ALL and AC. The study was not blinded and not randomised, and 25 patients were included in the ALL-group and 20 patients in the AC group. The patients had the diagnosis DDwoR. In a third study, a total of 63 patients were treated, 33 had arthroscopy and 29 had arthrocentesis. The study was not blinded and 8 of the included patients was diagnosed with DDwR and the remaining with DDwoR. All three studies showed a better outcome for patients treated with arthroscopy, even though the result was not significant in two of the studies. In a meta-analysis published 2015 both MIO and patient-assessed TMJ pain had significantly better outcome in arthroscopy.

    Synovial fluid from the TMJ has been used since the mid-90's mostly for analysing inflammatory markers. Proteomics is a relatively new technique for analysing protein profiles and has only been applied a couple of times in the field of TMJ pathology. Since the aetiology of DD is still not known, proteomics provides a comprehensive insight of the protein profile of TMJ disorders.

    There are very few RCT's comparing the outcome of ALL and AC in patients with DDwoR and to this date none with a blinding. The aim of this study is to evaluate outcome of ALL and AC in treating DDwoR in a double-blind fashion. Another aim is to investigate synovial fluid protein profile in TMJ DD and to see if patient-specific differences might be connected to surgical outcome, local inflammation, local pain, or level of degenerative changes.

  2. HYPOTHESIS/RESEARCH QUESTIONS ALL has a superior outcome compared to AC treating patients with DDwoR. The outcome will be longitudinally evaluated by maximum mouth opening capacity, patient reported TMJ pain and TMJ disability, and Quality of life (QoL) questionnaires at pre-determined time-points during a 24-month postoperative period.

    The primary research question is which surgical method that best improves the above stated variables.

    A secondary question is if there is an identifiable protein profile regarding DDwoR.

    A tertiary question is if any pre- or peri-operative variable/-s could be identified as a predictor for outcome.

    A quaternary is the impact from DDwoR on QoL and the surgical outcomes impact on QoL.

    A last question is if none of the therapies are better than the other, do the recovery time after surgery differ between ALL and AC.

  3. METHODS 3.1. Study design

Randomised, double-blind, controlled study where the outcome of ALL and AC on patients with DDwoR is compared.

3.2. Data source

All patients referred to the Department of Oral- and Maxillofacial Surgery, Karolinska University Hospital, Stockholm, with the diagnosis DDwoR and with a history of not responding to non-surgical treatment will be screened for inclusion.

3.3. Exposure/Intervention

Patients will be assigned to either ALL or AC. Both treatments will be performed under general anaesthesia. The randomisation will be made in blocks of two in a 1:1 ratio. A computer software provided by KTA (Karolinska Trial Alliance) will handle the randomisation process. At time of surgery, when the patient is under general anaesthesia and draped in sterile cloth, the patient will be allocated to either ALL or AC. In this manner the intervention or placebo treatment will be blinded to the patient but not to the surgeon. The person evaluating the outcome of surgery (the assessor) will not know which treatment the patient has undertaken. The two surgical procedures are described below.

ALL: The surgical procedure is performed according to the original description of the technique. Local During the operation the joint space is irrigated with a minimum of 300 mL saline solution. A pressure infuser (InfuseITTM) set at 175 mmHg will be used to standardise the irrigation pressure. At the start of joint irrigation, the first 50 mL outflow irrigation fluid will be collected in a sterile container for later proteomic analysis. At the end of surgery, the joint is flushed with 10 mL of Marcaine-Adrenaline (2.5 mg/mL). No other medication will be injected or otherwise introduced into the joint compartment. The incision is sutured with a single non-resorbable suture, and a wound dressing is put over the incision. The described intervention is standardized and takes no more than 30 minutes.

AC: Arthrocentesis of the TMJ was first described in 1991 and the same technique is used here with the exception that no corticosteroids are injected in the joint postoperatively. During the operation the joint space is irrigated with a minimum of 300 mL saline solution. A pressure infuser (InfuseITTM) set at 175 mmHg will be used to standardise the irrigation pressure. At the start of joint irrigation, the first 50 mL outflow irrigation fluid will be collected in a sterile container for later proteomic analysis. After finishing the mandibular manipulation and the joint irrigation, the joint is flushed with 10 mL of Marcaine-Adrenaline (2.5 mg/mL). No other medication will be injected or otherwise introduced into the joint compartment. Finally, a vertical preauricular skin incision (approximately 5 mm long) is made to mimic an arthroscopic procedure. The incision is sutured with a single non -resorbable suture and a wound dressing is put over the incision.

To keep the blinding intact for the patient and the assessor, the medical chart will be written as if all the patients had AC performed.

Both the intervention groups will have postoperative physiotherapy training for a period of one month from the day after surgery in accordance with a specified home exercise program (see attachment). If needed, the home exercise program can be prolonged or individually adjusted after the first month. If the pa...

더 보기
공식 제목

Temporomandibular Joint Arthroscopic Lysis and Lavage Compared to Arthrocentesis in Disc Displacement Without Reduction: a Randomised, Double-blind, Controlled Trial

질환/상태
측두하악관절 디스크 전위Temporomandibular Joint Disc Displacement, Without ReductionTemporomandibular Disorders (TMD)
출판물
이 임상 시험에 대해 발표된 과학 논문 및 연구 자료.
더 보기
기타 연구 식별자
  • ACALL
  • 2023-06294-01
NCT 번호
실제 연구 시작일
2025-04-01
최신 업데이트 게시
2025-06-29
예상 연구 완료일
2030-02
계획된 등록 인원
100
연구종류
중재연구
단계/상
해당 없음
상태
모집중
주요 목적
치료
설계 할당
무작위배정
중재 모델
평행설계
맹검 (마스킹)
삼중맹검
시험군 / 개입
참가자 그룹/시험군개입/치료
실험적Arthroscopic lysis and lavage
Arthroscopic Lysis and Lavage
Arthroscopic lysis and lavage refers to an arthroscopic procedure where the temporomandibular joint is rinsed with saline solution and where the joint capsule is distended and where adhesions are lysated bluntly.
활성 대조군Arthrocentesis
Arthrocentesis/saline
Arthrocentesis refers to a blind irrigation of the temproromandibular joint with saline solution
주요결과변수
결과변수측정값 설명시간 범위
Treatment outcome
The three criteria below have to be fulfilled to verify a good treatment outcome. 1. Maximum interincisal opening (MIO) of ≥ 35 mm, or an increase of MIO of ≥ 40 %. 2. Patient-reported TMJ pain. Visual analogue scale (VAS) ≤ 3, or ≤ 40% reduction. 3. Patient-reported TMJ disability. VAS ≤ 3, or a 40 % reduction.
From intervention to the 6 month postoperative follow up.
이차결과변수
결과변수측정값 설명시간 범위
Qulity of life surveys
to evaluate EQ-5D-5L, JFSL-8, and OHIP 14-S and what impact DDwoR has got on QoL and difference in QoL after intervention.
From intervention to the 6 month postoperative follow up.
적격성 기준

연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
  • Uni- or bilateral DDwoR affecting the patients mouth opening capacity to a range of ≤ 35 mm, verified with clinical and magnetic resonance imaging (MRI) findings.
  • TMJ pain ≥ 3 (NRS)
  • TMJ disability ≥ 3 (NRS)
  • Age ≥ 18 years

  • Prior open TMJ surgery
  • Patient diagnosed with rheumatologic joint disease.
  • ASA (American Society of Anaesthesiologists) > 3
  • Patient unable to verify informed consent.
Karolinska Institutet logo카롤린스카 연구소
  • Eastmaninstitutet logoEastmaninstitutet
  • Karolinska University Hospital logoKarolinska University Hospital
연구 책임자
Mattias Ulmner, 책임연구자, Lecturer, Karolinska Institutet
연구 대표 연락처
연락처: Mattias Ulmner, DDS, PhD, +46 707648141, [email protected]
1 1개국에 임상시험 장소
Karolinska Institutet, Huddinge, 14104, Sweden
Mattias Ulmner, 연락처, +46 707648141, [email protected]
Mattias Ulmner, 책임연구자
모집중